SBIR/STTR Research Award
PHASE II DEVELOPMENT OF RAPID MOLECULAR ASSAY FOR POINT OF CARE DETECTION OF TREPONEMA PALLIDUM
Award amount
$1,488,107Program and phase
SBIR · Phase IIAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TETRACORE, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- V7HKYLEP7N37
- Solicitation number
- PHS-2022-1
- Topic code
- 108
Research abstract
To support the development of rapid molecular assay for point of care detection of Treponema Pallidum.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rapid Point-of-Care Molecular Test for the Differentiation of Dengue and Chikungunya Viruses
- Detection of Mycobacterium paratuberculosis in Bulk Tank Milk Filters
- DEVELOPMENT OF A DEVICE FOR RAPID DETECTION OF ANTHRAX
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Assessment of Deep Learning Classification Methods for Parkinsonism
- Discovery of GPR171 small molecule ligands for the treatment of chronic pain
- Targeting TLR4-lipid rafts to prevent postoperative pain
- Passive intracranial pressure sensor for hydrocephalus shunts and cranioplasty implants with ultrasound readout
- SBIR TOPIC 108, FAST-TRACK - DEVICE SYSTEM FOR TRANSCATHETER REPAIR OF POSTINFARCTION VENTRICULAR SEPTAL DEFECT
Research funding history
4 SBIR/STTR records share this UEI (2002–2024). Reported award amounts total $1,897,535. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Agriculture